Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Follicular Lymphoma (FL) treatment initiation is largely determined by tumor burden and symptoms. In the pre-rituximab era, the Group d’Etude des Lymphomes Folliculaires (GELF) developed widely adopted criteria to identify high tumor burden FL patients to harmonize clinical trial populations. The u...
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Ferrata Storti Foundation
2024-03-01
|
Edice: | Haematologica |
On-line přístup: | https://haematologica.org/article/view/11497 |